Company intelligence / Profile preview

Photonome

Creve Coeur, Missouri, United Statesjustdropped.com ↗
Ownership
Private
Development stage
Other
01

Overview

Photonome develops proprietary phototrophic microbial consortia that function as "microbial cover crops" to fix nitrogen and sequester carbon dioxide into soils, aiming to improve soil health and reduce fertilizer needs. The technology originated at MOgene Green with DOE funding and internal research. The company has rebranded to focus on commercialization of this platform. There are no clinical results as it is not a healthcare product.

Modalities
Microbial therapy (specifically microbial consortia for soil application)
Industry
Agriculture & AgTech

Beyond the preview

Go deeper on Photonome.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Photonome.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call